Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4624211rdf:typepubmed:Citationlld:pubmed
pubmed-article:4624211lifeskim:mentionsumls-concept:C0301508lld:lifeskim
pubmed-article:4624211lifeskim:mentionsumls-concept:C1552104lld:lifeskim
pubmed-article:4624211lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:4624211lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:4624211lifeskim:mentionsumls-concept:C0003261lld:lifeskim
pubmed-article:4624211lifeskim:mentionsumls-concept:C0441800lld:lifeskim
pubmed-article:4624211pubmed:issue5lld:pubmed
pubmed-article:4624211pubmed:dateCreated1972-8-8lld:pubmed
pubmed-article:4624211pubmed:abstractTextA dosage equal to or greater than approximately 3.4 Dex (decimal exponent, log(10)) weanling mouse intracerebral 50% lethal dose (LD(50)) was sufficient to elicit a yellow fever antibody response, as determined by the plaque neutralization (PN) test, in better than 90% of vaccinated rhesus monkeys. Lower dosages were progressively less effective in terms of PN titers and the PN and hemagglutination-inhibition serological conversion rates observed. A dose of between 3.4 and 4.2 Dex weanling mouse intracerebral LD(50), or one-tenth to one times the dosage recommended for man, provided an optimal antibody response in monkeys. In rhesus monkeys, in contrast to the findings for man, pre-existing yellow fever antibody did not interfere with the antibody response to yellow fever vaccine. The PN test was felt to be a more sensitive and specific indicator of yellow fever antibody in rhesus monkeys after vaccination than the hemagglutination inhibition or complement fixation tests.lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:languageenglld:pubmed
pubmed-article:4624211pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:citationSubsetIMlld:pubmed
pubmed-article:4624211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4624211pubmed:statusMEDLINElld:pubmed
pubmed-article:4624211pubmed:monthMaylld:pubmed
pubmed-article:4624211pubmed:issn0003-6919lld:pubmed
pubmed-article:4624211pubmed:authorpubmed-author:O'BrienT CTClld:pubmed
pubmed-article:4624211pubmed:authorpubmed-author:TrimmerR WRWlld:pubmed
pubmed-article:4624211pubmed:authorpubmed-author:MasonR ARAlld:pubmed
pubmed-article:4624211pubmed:authorpubmed-author:GinnR KRKlld:pubmed
pubmed-article:4624211pubmed:authorpubmed-author:TaurasoN MNMlld:pubmed
pubmed-article:4624211pubmed:issnTypePrintlld:pubmed
pubmed-article:4624211pubmed:volume23lld:pubmed
pubmed-article:4624211pubmed:ownerNLMlld:pubmed
pubmed-article:4624211pubmed:authorsCompleteYlld:pubmed
pubmed-article:4624211pubmed:pagination908-13lld:pubmed
pubmed-article:4624211pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:meshHeadingpubmed-meshheading:4624211-...lld:pubmed
pubmed-article:4624211pubmed:year1972lld:pubmed
pubmed-article:4624211pubmed:articleTitleYellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.lld:pubmed
pubmed-article:4624211pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4624211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4624211lld:pubmed